Profound Medical Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Profound Medical's estimated annual revenue is currently $44.7M per year.(i)
  • Profound Medical's estimated revenue per employee is $251,000

Employee Data

  • Profound Medical has 178 Employees.(i)
  • Profound Medical grew their employee count by 3% last year.

Profound Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Architect and VP Software DevelopmentReveal Email/Phone
3
VP Business DevelopmentReveal Email/Phone
4
VP MarketingReveal Email/Phone
5
VP Business DevelopmentReveal Email/Phone
6
VP Product Management & RAReveal Email/Phone
7
VP, Product DevelopmentReveal Email/Phone
8
SVP Product Leader (TULSA-PRO)Reveal Email/Phone
9
Director, Market Access, Profound MedicalReveal Email/Phone
10
Global Director People Development and CultureReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.1M124-4%N/AN/A
#2
$4M16-6%N/AN/A
#3
$78.3M3129%N/AN/A
#4
$23.1M926%N/AN/A
#5
$9.3M379%N/AN/A
#6
$75.3M2403%$53.9MN/A
#7
$267.6M106613%N/AN/A
#8
$36.6M0N/A$1.3BN/A
#9
$30.9M123-20%N/AN/A
#10
$8.5M34-17%N/AN/A
Add Company

What Is Profound Medical?

AN INSIDE OUT APPROACH TO PROSTATE ABLATION\r\n\r\nProfound Medical is a Canadian medical device company that has developed a unique and minimally invasive procedure to ablate the prostate gland in prostate cancer patients. \r\n\r\nProfound’s novel technology combines real-time MR imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. It provides a highly precise treatment tailored to patient-specific anatomy and pathology. This method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery. \r\n\r\nFor more information, visit profoundmedical.com

keywords:N/A

N/A

Total Funding

178

Number of Employees

$44.7M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Profound Medical News

2022-04-17 - Financial Contrast: LENSAR (NASDAQ:LNSR) and Profound ...

Profound Medical is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two...

2022-04-17 - Profound Medical (NASDAQ:PROF) PT Set at $22.00 by ...

Profound Medical (NASDAQ:PROF – Get Rating) has been given a $22.00 target price by equities research analysts at Raymond James in a...

2022-04-13 - Profound Medical to Release First Quarter 2022 Financial ...

(NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$46.8M1789%N/A
#2
$49.4M1798%N/A
#3
$65.3M18127%N/A
#4
$45.9M18419%N/A
#5
$66.7M1855%N/A